Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/26/2024
Alphamab Initiates Phase I/II Trial for HER2 ADC Bispecific and PD-L1 ...
12/24/2024
Roche's Lunsumio (Mosunetuzumab) Gains NMPA Approval for r/r Follicula...
12/24/2024
State Council Moves to Advance Pharma Reforms and Regulatory Streamlin...
12/24/2024
WuXi Biologics to Divest Advanced Therapies Unit Amid U.S. Restriction...
12/23/2024
Sanofi Acquires Rights to Cytokinetics's Aficamten in Greater China
12/23/2024
MSD Finalizes Exclusive Global License Deal for Anti-PD-1 LM-299
12/23/2024
Roch Secures Chinese Approval of Lunsumio (Mosunetuzumab) for r/r Fol...
12/23/2024
RAPT Thera and Jemincare Enter License Deal for Novel Long-Acting an...
12/20/2024
China Licenses First Wholly Foreign-Owned Third-Grade General Hospital...
12/20/2024
Recent Executive Moves
12/19/2024
Palleon and Henlius Collaborate to Advance Glycan Editing for Autoimmu...
12/19/2024
BMS China Regains Rights to GPC3 Targeted Drug ABZ-706 in Greater Chin...
12/18/2024
Merck and Hansoh Enter into Global License Deal for Investigational Or...
12/18/2024
BMS and Fangzhou Forge Strategic Alliance to Advance Digital Healthcar...
12/17/2024
Eli Lilly's Alzheimer's Drug Donanemab Secures Approval in China
12/16/2024
Everest Medicines Announces Acceptance of the NDA for VELSIPITY
12/16/2024
Candid Therapeutics and EpimAb Biotherapeutics Enter Into Research Col...
12/16/2024
Mabwell Plans Hong Kong Dual Listing Amid Shifting Market Dynamics
12/16/2024
Sinopharm's Mpox Vaccine Gains Clinical Trial Approval in China
12/15/2024
HUTCHMED Announces Breakthru Designation in China for ORPATHYS and TA...
12/15/2024
National Healthcare Security Work Conference Highlights Progress and S...
12/13/2024
RemeGen Unveils Phase III Study Results of Disitamab Vedotin in HER2-P...
12/13/2024
Recent Executive Moves
12/12/2024
Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
12/12/2024
Bayer Co.Lab Expands in China with Three New Biotech Partners
12/12/2024
Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
12/12/2024
JPO Publicizes the Proposed Results of the 10th National VBP
12/11/2024
South China Public Hospitals Slash Salaries Amid Mounting Financial Pr...
12/11/2024
Santhera Wins First Chinese Approval for Duchenne Muscular Dystrophy ...
12/10/2024
The Proposed BIOSECURE Act Faces Setback in Senate
Page:
11
/
354
Total number of articles:
10618
:
[First]
[<<]
[9]
[10]
[11]
[12]
[13]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit